A diagnostic immunohistochemical panel for yolk sac (primitive endodermal) tumours based on an immunohistochemical comparison with the human yolk sac

Histopathology

Volumn 65, Issue 1, 2014, Pages 51-59

  Nogales, Francisco F ^a   Quiñonez, Enoe ^a   López Marín, Laura ^b   Dulcey, Isabel ^a   Preda, Ovidiu ^c  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b Dr Abelardo Buch López Institute of Nephrology   (Cuba)

^c Master Diagnostica   (Spain)

Author keywords

Human yolk sac; Immunohistochemistry; Pluripotentiality; Primitive endodermal tumour; Yolk sac tumours

Indexed keywords

ALPHA FETOPROTEIN; GLYPICAN 3; HEPATOCYTE PARAFFIN 1; LIN28 PROTEIN; PROTEIN; SALL4 PROTEIN; THYROID TRANSCRIPTION FACTOR 1; TRANSCRIPTION FACTOR CDX2; TUMOR MARKER; UNCLASSIFIED DRUG; VILLIN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CHILD; CLEAR CELL CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; EMBRYO; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFANT; MALE; MIDDLE AGED; OVARY TUMOR; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHOOL CHILD; SERODIAGNOSIS; TESTIS TUMOR; TUMOR DIFFERENTIATION; YOLK SAC; YOLK SAC TUMOR; YOUNG ADULT; ADOLESCENT; ENDODERMAL SINUS TUMOR; METABOLISM;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; ENDODERMAL SINUS TUMOR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFANT; MALE; MIDDLE AGED; TUMOR MARKERS, BIOLOGICAL; YOLK SAC; YOUNG ADULT;

EID: 84902083746     PISSN: 03090167     EISSN: 13652559     Source Type: Journal    
DOI: 10.1111/his.12373     Document Type: Article

References (33)

1. Prat JC, Cao D, Carinelli SG, Nogales FF, Vang R, Zaloudek CJ. Germ cell tumours. In Kurman R, Young RH eds. World Health Organization classification of tumours. Tumours of the female genital organs. Lyon: IARC Press, 2014.
2. Nogales FF, Preda O, Nicolae A. Yolk sac tumours revisited. A review of their many faces and names. Histopathology 2012; 60; 1023-1033.
3. Takashina T. Histology of the secondary human yolk sac with special reference to hematopoesis. In Nogales FF ed. The human yolk sac and yolk sac tumours. Berlin: Springer-Verlag, 1993; 48-69
4. Gonzalez-Crussi F, Roth LM. The human yolk sac and yolk sac carcinoma An ultrastructural study. Hum. Pathol. 1976; 7; 675-691.
5. Nogales-Fernandez F, Silverberg SG, Bloustein PA et al. Yolk sac carcinoma (endodermal sinus tumor): ultrastructure and histogenesis of gonadal and extragonadal tumors in comparison with normal human yolk sac. Cancer 1977; 39; 1462-1474.
6. Nogales FF, Dulcey I. The secondary human yolk sac has an immunophenotype indicative of both hepatic and intestinal differentiation. Int. J. Dev. Biol. 2012; 56; 755-760.
7. Teilum G. Endodermal sinus tumors of the ovary and testis. Comparative morphogenesis of the so-called mesoephroma ovarii (Schiller) and extraembryonic (yolk sac-allantoic) structures of the rat's placenta. Cancer 1959; 12; 1092-1105.
8. Pierce GB, Dixon FJ Jr. Testicular teratomas. I. Demonstration of teratogenesis by metamorphosis of multipotential cells. Cancer 1959; 12; 573-583.
9. Pierce GB, Dixon FJ Jr. Testicular teratomas. II. Teratocarcinoma as an ascitic tumor. Cancer 1959; 12; 584-589.
10. Takashina T, Kanda Y, Hayakawa O et al. Yolk sac tumors of the ovary and the human yolk sac. Am. J. Obstet. Gynecol. 1987; 156; 223-229.
11. Jauniaux E, Gulbis B. Fluid compartments of the embryonic environment. Hum. Reprod. Update 2000; 6; 268-278.
12. Norgaard-Pedersen B, Albrechtsen R, Teilum G. Serum alpha-foetoprotein as a marker for endodermal sinus tumour (yolk sac tumour) or a vitelline component of 'teratocarcinoma'. Acta Pathol. Microbiol. Scand. A 1975; 83; 573-589.
13. Xue D, Peng Y, Wang F et al. RNA-binding protein LIN28 is a sensitive marker of ovarian primitive germ cell tumours. Histopathology 2011; 59; 452-459.
14. Preda O, Dema A, Iacob M et al. Urothelial carcinoma of the renal pelvis with simultaneous trophoblastic and malignant clear cell endodermal-type differentiation. Virchows Arch. 2012; 460; 353-356.
15. Zynger DL, McCallum JC, Luan C et al. Glypican 3 has a higher sensitivity than alpha-fetoprotein for testicular and ovarian yolk sac tumour: immunohistochemical investigation with analysis of histological growth patterns. Histopathology 2010; 56; 750-757.
16. Preda O, Nicolae A, Aneiros-Fernandez J et al. Glypican 3 is a sensitive, but not a specific, marker for the diagnosis of yolk sac tumours. Histopathology 2011; 58; 312-314; author reply 314-315.
17. Esheba GE, Pate LL, Longacre TA. Oncofetal protein glypican-3 distinguishes yolk sac tumor from clear cell carcinoma of the ovary. Am. J. Surg. Pathol. 2008; 32; 600-607.
18. Pitman MB, Triratanachat S, Young RH et al. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma. Int. J. Gynecol. Pathol. 2004; 23; 58-64.
19. Pelosi G, Petrella F, Sandri MT et al. A primary pure yolk sac tumor of the lung exhibiting CDX-2 immunoreactivity and increased serum levels of alkaline phosphatase intestinal isoenzyme. Int. J. Surg. Pathol. 2006; 14; 247-251.
20. Bing Z, Pasha T, Tomaszewski JE et al. CDX2 expression in yolk sac component of testicular germ cell tumors. Int. J. Surg. Pathol. 2009; 17; 373-377.
21. Wong HH, Chu P. Immunohistochemical features of the gastrointestinal tract tumors. J. Gastrointest. Oncol. 2012; 3; 262-284.
22. Cao D, Li J, Guo CC et al. SALL4 is a novel diagnostic marker for testicular germ cell tumors. Am. J. Surg. Pathol. 2009; 33; 1065-1077.
23. Cao D, Guo S, Allan RW et al. SALL4 is a novel sensitive and specific marker of ovarian primitive germ cell tumors and is particularly useful in distinguishing yolk sac tumor from clear cell carcinoma. Am. J. Surg. Pathol. 2009; 33; 894-904.
24. Wang F, Liu A, Peng Y et al. Diagnostic utility of SALL4 in extragonadal yolk sac tumors: an immunohistochemical study of 59 cases with comparison to placental-like alkaline phosphatase, alpha-fetoprotein, and glypican-3. Am. J. Surg. Pathol. 2009; 33; 1529-1539.
25. Khalifa MA, Gersell DJ, Hansen CH et al. Hepatic (hepatocellular) adenoma of the placenta: a study of four cases. Int. J. Gynecol. Pathol. 1998; 17; 241-244.
26. Thornton JE, Gregory RI. How does Lin28 let-7 control development and disease? Trends Cell Biol. 2012; 22; 474-482.
27. Gillis AJ, Stoop H, Biermann K et al. Expression and interdependencies of pluripotency factors LIN28, OCT3/4, NANOG and SOX2 in human testicular germ cells and tumours of the testis. Int. J. Androl. 2011; 34; e160-e174.
28. Cox JL, Mallanna SK, Luo X et al. Sox2 uses multiple domains to associate with proteins present in Sox2-protein complexes. PLoS ONE 2010; 5; e15486.
29. West JA, Viswanathan SR, Yabuuchi A et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009; 460; 909-913.
30. Cao D, Allan RW, Cheng L et al. RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum. Pathol. 2011; 42; 710-718.
31. Cao D, Liu A, Wang F et al. RNA-binding protein LIN28 is a marker for primary extragonadal germ cell tumors: an immunohistochemical study of 131 cases. Mod. Pathol. 2011; 24; 288-296.
32. Nogales FF, Dulcey I, Preda O. Issues in gynecologic pathology. Germ cell tumors of the ovary. An update. Arch. Pathol. Lab. Med. 2014; 138; 351-362.
33. Nogales FF, Bergeron C, Carvia RE et al. Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases. Am. J. Surg. Pathol. 1996; 20; 1056-1066.